Investment deal value in pharmaceutical market in China 2016-2019
Merger and acquisition (M&A) activities remained active in the health and pharmaceuticals market in China. In 2019, the value of investment deal in China's pharmaceutical sector amounted to around 22.2 billion U.S. dollars, up 12 percent from 19.8 billion U.S. dollars in the previous year.